Shareholding disclosure

Jeff Comisarow

Declared position

6.16%

Threshold

Crossed upwards

Timeline

Published

28.05.2014

Transaction

19.05.2014

Voting rights breakdown

Voting rights acquired6.16%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAE5R00027

Beneficial owner

Jeff Comisarow

Declared address

Jeff Comisarow, New York, NY 10017

Habe gestern abend die korrigierte Version von Jeff Comisarow erhalten. The direct buyer (1) is a fund (limited liability company) incorporated in Delware in 2013 of whom the director is the indirect buyer (2) which is owned by the beneficial owner

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Jeff Comisarow

Santhera Pharmaceuticals Holding AG28.05.2014TAE5R00027

Disclosure summary

Jeff Comisarow disclosed a holding in Santhera Pharmaceuticals Holding AG on the acquisition side, published by SIX Exchange Regulation on 28.05.2014, at 6.16% of voting rights. Notice category: Single shareholder.

Disclosed position

6.16%

Voting rights acquired

Voting rights acquired6.16%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Jeff Comisarow disclosed a holding in Santhera Pharmaceuticals Holding AG, published on 28.05.2014.

Publication date28.05.2014

Transaction date19.05.2014

Issuing companySanthera Pharmaceuticals Holding AG

Beneficial ownerJeff Comisarow

Declared addressJeff Comisarow, New York, NY 10017

CategorySingle shareholder

Voting rights acquired6.16%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAE5R00027

Conditions

Habe gestern abend die korrigierte Version von Jeff Comisarow erhalten. The direct buyer (1) is a fund (limited liability company) incorporated in Delware in 2013 of whom the director is the indirect buyer (2) which is owned by the beneficial owner

Source: SIX Exchange Regulation · Publication date: 28.05.2014

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open